Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease.
Ontology highlight
ABSTRACT: Objective: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder. Neurofilament light protein (NfL) is correlated with clinical severity of HD but relative data are the lack in the Chinese population. Reactive astrocytes are related to HD pathology, which predicts their potential to be a biomarker in HD progression. Our aim was to discuss the role of blood glial fibrillary acidic protein (GFAP) to evaluate clinical severity in patients with HD. Methods: Fifty-seven HD mutation carriers (15 premanifest HD, preHD, and 42 manifest HD) and 26 healthy controls were recruited. Demographic data and clinical severity assessed with the internationally Unified Huntington's Disease Rating Scale (UHDRS) were retrospectively analyzed. Plasma NfL and GFAP were quant
SUBMITTER: You H
PROVIDER: S-EPMC8639701 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA